Showing results (11-20 of 32) with videos related to
Sort By:
Pageof 4
Radiation Protection Dosimetry|March 13, 2026
Modelling the relative precision of whole-kidney dosimetry in molecular radiotherapy using a power law approachJehangir Khan, Tobias Rydén, Martijn van Essen, et al.The International Journal of Cardiovascular Imaging|November 28, 2015
18F-FDG PET/CT in the diagnosis of prosthetic valve endocarditisErika Fagman, Martijn van Essen, Johan Fredén Lindqvist, et al.The American Journal of Emergency Medicine|August 8, 2012
Unnecessary surgery for acute abdomen secondary to angiotensin-converting enzyme inhibitor useLaura C G de Graaff, Martijn van Essen, Eleonora M Schipper, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 29, 2011
Quality of life in 265 patients with gastroenteropancreatic or bronchial neuroendocrine tumors treated with [177Lu-DOTA0,Tyr3]octreotateSaima Khan, Eric P Krenning, Martijn van Essen, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 24, 2019
Bone Marrow Absorbed Doses and Correlations with Hematologic Response During 177Lu-DOTATATE Treatments Are Influenced by Image-Based Dosimetry Method and Presence of Skeletal MetastasesLinn Hagmarker, Johanna Svensson, Tobias Rydén, et al.Nature Reviews. Endocrinology|June 3, 2009
Peptide-receptor radionuclide therapy for endocrine tumorsMartijn van Essen, Eric P Krenning, Boen L R Kam, et al.European Journal of Nuclear Medicine and Molecular Imaging|January 12, 2008
Report on short-term side effects of treatments with 177Lu-octreotate in combination with capecitabine in seven patients with gastroenteropancreatic neuroendocrine tumoursMartijn van Essen, Eric P Krenning, Boen L Kam, et al.European Journal of Nuclear Medicine and Molecular Imaging|January 30, 2007
Peptide receptor radionuclide therapy with 177Lu-octreotate in patients with foregut carcinoid tumours of bronchial, gastric and thymic originMartijn van Essen, Eric P Krenning, Willem H Bakker, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 13, 2010
Salvage therapy with (177)Lu-octreotate in patients with bronchial and gastroenteropancreatic neuroendocrine tumorsMartijn van Essen, Eric P Krenning, Boen L R Kam, et al.EJNMMI Physics|May 9, 2026
Multiple vertebrae improves precision in image-based bone marrow absorbed dose estimation in [177Lu]Lu-DOTATATE treatmentKatja Smits, Frida Westerbergh, Jens Hemmingsson, et al.Pageof 4